GERD clinical trials

Explore recruiting gerd clinical trials.

Recruiting gerd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

GERD trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, phase 3, double-blind, double-dummy, active comparator-controlled multicenter clinical trial to evaluate the efficacy and safety of linaprazan glurate compared to lansoprazole in maintenance of healing in participants with healed erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) of Los Angeles (LA) grades A to D

Hungary, Germany, Romania, Bulgaria, Czechia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, phase 3, double-blind, double-dummy, active comparator-controlled multicenter study to evaluate the efficacy and safety of 2 doses of linaprazan glurate compared to lansoprazole in 4 or 8 weeks healing in participants with erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD) of Los Angeles (LA) grades A to D

Germany, Poland, Hungary, Bulgaria, Romania, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Double-Blind, 12 Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 2 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of Gastroesophageal Reflux Disease in Infants- a Randomized Controlled Trial

Denmark

Phase III and phase IV (Integrated) EU CTIS Study details

Interest of systematic treatment with PPI after endoscopic myotomy compared to PPI treatment in case of symptoms in prevention of gastroesophageal reflux after POEM for esophageal achalasia. Randomized open-label clinical trial

France

Therapeutic use (Phase IV) EU CTIS Study details

An open, single arm, single-center, Phase 1 trial investigating the effect of 7-days-repeated administration of linaprazan glurate on the pharmacokinetics of repeated doses of an approved antibiotic in healthy participants

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

GERD trials by city

GERD in Toronto GERD in Vancouver GERD in Montreal GERD in Calgary GERD in Edmonton GERD in Ottawa GERD in Winnipeg GERD in Quebec City GERD in Hamilton GERD in Kitchener GERD in London GERD in Halifax GERD in New York GERD in Los Angeles GERD in Chicago GERD in Houston

Other conditions

Substance use disorder COPD Asthma Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea Chronic cough Crohn's disease Ulcerative colitis Irritable bowel syndrome Celiac disease Eosinophilic esophagitis Gastroparesis Rheumatoid arthritis Lupus Psoriatic arthritis Ankylosing spondylitis Osteoarthritis Knee osteoarthritis Osteoporosis Sjogren's syndrome Scleroderma Fibromyalgia